Last reviewed 2026-04-22 · How we verify

Adjuvanted Hep B vaccine Lot 3

Henogen · Phase 3 active Biologic

Adjuvanted Hep B vaccine Lot 3 is a Vaccine Biologic drug developed by Henogen. It is currently in Phase 3 development for Prevention of hepatitis B infection.

This adjuvanted hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen.

This adjuvanted hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen. Used for Prevention of hepatitis B infection.

At a glance

Generic name	Adjuvanted Hep B vaccine Lot 3
Sponsor	Henogen
Drug class	Vaccine
Target	Hepatitis B surface antigen (HBsAg)
Modality	Biologic
Therapeutic area	Immunology
Phase	Phase 3

Mechanism of action

The vaccine contains hepatitis B surface antigen (HBsAg) combined with an adjuvant that enhances the immunogenicity of the antigen. The adjuvant amplifies the body's innate immune response, leading to stronger and more durable antibody production and T-cell activation against HBsAg. This provides protection against hepatitis B virus infection.

Approved indications

Prevention of hepatitis B infection

Common side effects

Injection site pain or erythema
Fatigue
Myalgia
Headache
Low-grade fever

Key clinical trials

Consistency Study of Three Lots of Henogen's Adjuvanted Hepatitis B Vaccine When Given in 0, 1 Month Schedule (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Adjuvanted Hep B vaccine Lot 3 CI brief — competitive landscape report
Adjuvanted Hep B vaccine Lot 3 updates RSS · CI watch RSS
Henogen portfolio CI

Frequently asked questions about Adjuvanted Hep B vaccine Lot 3

What is Adjuvanted Hep B vaccine Lot 3?

Adjuvanted Hep B vaccine Lot 3 is a Vaccine drug developed by Henogen, indicated for Prevention of hepatitis B infection.

How does Adjuvanted Hep B vaccine Lot 3 work?

This adjuvanted hepatitis B vaccine stimulates the immune system to produce antibodies and cellular immunity against hepatitis B virus surface antigen.

What is Adjuvanted Hep B vaccine Lot 3 used for?

Adjuvanted Hep B vaccine Lot 3 is indicated for Prevention of hepatitis B infection.

Who makes Adjuvanted Hep B vaccine Lot 3?

Adjuvanted Hep B vaccine Lot 3 is developed by Henogen (see full Henogen pipeline at /company/henogen).

What drug class is Adjuvanted Hep B vaccine Lot 3 in?

Adjuvanted Hep B vaccine Lot 3 belongs to the Vaccine class. See all Vaccine drugs at /class/vaccine.

What development phase is Adjuvanted Hep B vaccine Lot 3 in?

Adjuvanted Hep B vaccine Lot 3 is in Phase 3.

What are the side effects of Adjuvanted Hep B vaccine Lot 3?

Common side effects of Adjuvanted Hep B vaccine Lot 3 include Injection site pain or erythema, Fatigue, Myalgia, Headache, Low-grade fever.

What does Adjuvanted Hep B vaccine Lot 3 target?

Adjuvanted Hep B vaccine Lot 3 targets Hepatitis B surface antigen (HBsAg) and is a Vaccine.

Drug class: All Vaccine drugs
Target: All drugs targeting Hepatitis B surface antigen (HBsAg)
Manufacturer: Henogen — full pipeline
Therapeutic area: All drugs in Immunology
Indication: Drugs for Prevention of hepatitis B infection
Compare: Adjuvanted Hep B vaccine Lot 3 vs similar drugs
Pricing: Adjuvanted Hep B vaccine Lot 3 cost, discount & access